Aster DM Healthcare Limited

NSEI:ASTERDM Stock Report

Market Cap: ₹218.9b

Aster DM Healthcare Valuation

Is ASTERDM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ASTERDM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ASTERDM (₹439.85) is trading above our estimate of fair value (₹351.36)

Significantly Below Fair Value: ASTERDM is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASTERDM?

Key metric: As ASTERDM is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ASTERDM. This is calculated by dividing ASTERDM's market cap by their current earnings.
What is ASTERDM's PE Ratio?
PE Ratio96.9x
Earnings₹2.26b
Market Cap₹218.95b

Price to Earnings Ratio vs Peers

How does ASTERDM's PE Ratio compare to its peers?

The above table shows the PE ratio for ASTERDM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average59.5x
MEDANTA Global Health
60.6x20.2%₹296.0b
NH Narayana Hrudayalaya
33x13.6%₹256.7b
KIMS Krishna Institute of Medical Sciences
72.3x24.3%₹239.7b
RAINBOW Rainbow Children's Medicare
72.1x23.2%₹167.0b
ASTERDM Aster DM Healthcare
96.9x37.5%₹218.9b

Price-To-Earnings vs Peers: ASTERDM is expensive based on its Price-To-Earnings Ratio (96.9x) compared to the peer average (59.5x).

Price to Earnings Ratio vs Industry

How does ASTERDM's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.96m
No more companies available in this PE range
ASTERDM 96.9xIndustry Avg. 43.1xNo. of Companies6PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ASTERDM is expensive based on its Price-To-Earnings Ratio (96.9x) compared to the Indian Healthcare industry average (43.1x).

Price to Earnings Ratio vs Fair Ratio

What is ASTERDM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASTERDM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio96.9x
Fair PE Ratio90x

Price-To-Earnings vs Fair Ratio: ASTERDM is expensive based on its Price-To-Earnings Ratio (96.9x) compared to the estimated Fair Price-To-Earnings Ratio (90x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ASTERDM forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹439.85
₹491.88
+11.8%
6.0%₹535.00₹435.00n/a8
Nov ’25₹444.90
₹491.88
+10.6%
6.0%₹535.00₹435.00n/a8
Oct ’25₹417.35
₹424.00
+1.6%
5.5%₹457.00₹385.00n/a8
Sep ’25₹406.70
₹419.29
+3.1%
5.0%₹450.00₹385.00n/a7
Aug ’25₹368.20
₹410.83
+11.6%
5.8%₹450.00₹370.00n/a6
Jul ’25₹350.60
₹410.83
+17.2%
5.8%₹460.00₹385.00n/a6
Jun ’25₹363.95
₹410.83
+12.9%
5.8%₹460.00₹385.00n/a6
May ’25₹348.15
₹489.00
+40.5%
2.8%₹515.00₹480.00n/a5
Apr ’25₹408.05
₹486.00
+19.1%
1.6%₹500.00₹480.00n/a5
Mar ’25₹462.05
₹486.00
+5.2%
1.6%₹500.00₹480.00n/a5
Feb ’25₹432.10
₹420.00
-2.8%
1.7%₹430.00₹410.00n/a5
Jan ’25₹403.95
₹420.00
+4.0%
1.7%₹430.00₹410.00n/a5
Dec ’24₹401.25
₹396.67
-1.1%
13.3%₹430.00₹280.00n/a6
Nov ’24₹329.95
₹327.38
-0.8%
11.1%₹380.00₹262.00₹444.908
Oct ’24₹327.90
₹320.44
-2.3%
12.3%₹380.00₹262.00₹417.359
Sep ’24₹329.95
₹319.89
-3.0%
12.2%₹380.00₹262.00₹406.709
Aug ’24₹319.75
₹305.78
-4.4%
9.1%₹350.00₹262.00₹368.209
Jul ’24₹280.20
₹298.44
+6.5%
9.8%₹350.00₹262.00₹350.609
Jun ’24₹270.50
₹298.44
+10.3%
9.8%₹350.00₹262.00₹363.959
May ’24₹246.95
₹270.67
+9.6%
7.2%₹310.00₹235.00₹348.159
Apr ’24₹240.70
₹266.78
+10.8%
5.8%₹290.00₹235.00₹408.059
Mar ’24₹219.00
₹266.67
+21.8%
5.8%₹290.00₹235.00₹462.059
Feb ’24₹209.55
₹276.44
+31.9%
6.4%₹300.00₹250.00₹432.109
Jan ’24₹231.10
₹276.44
+19.6%
6.4%₹300.00₹250.00₹403.959
Dec ’23₹232.20
₹276.44
+19.1%
6.4%₹300.00₹250.00₹401.259
Nov ’23₹249.65
₹253.22
+1.4%
7.3%₹290.00₹230.00₹329.959

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yatharth Hospital & Trauma Care Services

₹51.9b

Owns and operates super-specialty hospitals in Delhi and Madhya Pradesh.

543950

₹604.50

7D

0.02%

1Y

39.9%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

7D

-3.9%

1Y

n/a

N G Industries

₹565.2m

Provides various healthcare services in India.

530897

₹168.70

7D

-0.3%

1Y

0.8%